Market by Cellulite Type, Procedure Type, End-user, and Country Outlook | Forecast 2023-2030
Triton Market Research’s report denotes that the cellulite treatment market in North America is estimated to propel with a compound annual growth rate of 9.58% during the forecasted years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries explored in the region are:
•
United States
•
Canada
The regional market’s growth is fueled by the
growing strategic developments by players like Johnson & Johnson, Sientra
Inc, etc. Other than this, the rise in cosmetic procedures and the increase in
plastic surgeons have also boosted the growth of the cellulite treatment
market. However, stringent regulations pertaining to treatment approvals might
restrict the studied market’s overall development across the US and Canada.
The
United States accounts for the largest market share in the region. This growth is on account of soaring demand
for aesthetic procedures like cellulite reduction. Moreover, technological
advancements and high disposable income have shifted consumer focus towards
enhancing their appearance, resulting in the expansion of the personal care
industry. As per estimates, the country hosted the highest number of plastic
surgeons in 2021. These factors thus accelerate the cellulite treatment
market’s development.
Further, the country has witnessed a surge in
obesity levels over the past few years. As per CDC, obesity prevalence was
nearly 41.9% in 2020. This high rise in cases has been mainly due to changing
lifestyles and eating habits. As a result, consumers are opting for cellulite
reduction procedures, which adds to the US cellulite treatment market.
Edematous cellulite is the most severe form
associated with poor blood circulation. This type is usually apparent on the knees,
thighs, and lower legs. In this regard, lymphatic drainage is one of the most
beneficial treatments, as it unlocks the ducts in the knee and ankle. The trend
of improving one’s physical appearance has increased demand for such
treatments. The market’s growth is
assessed based on cellulite type, procedure type, and end-user. The
cellulite type includes edematous, soft, and hard cellulite.
The key companies in the market are AbbVie Inc, Bausch Health Companies Inc,
Cutera Inc, Inceler Medikal, and Zimmer
MedizinSysteme GmbH.
AbbVie Inc is a global research-based
biopharmaceutical company offering products for immunology, neuroscience,
aesthetics, hematologic oncology, and eye treatments. Its aesthetic product
line includes facial injectables, skincare and body contouring, and
regenerative products. One of the products includes Resonic, a rapid acoustic
pulse device to improve cellulite appearance. The company has main R&D
facilities in Germany, with operations across North America, Asia-Pacific, etc.
Key deliverables of the report:
● Market CAGR during the forecasting years 2023-2030
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the cellulite treatment market revenue growth in North America and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the NA
cellulite treatment market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Category, Applicatio ..
VIEW REPORT
Market by RTD Type | Forecast ..
VIEW REPORT
Market by Product Type | Forec ..
VIEW REPORT
Market by Product, Application ..
VIEW REPORT
Market By Product Type, Specie ..
VIEW REPORT
Market by Ingredient Type, Age ..
VIEW REPORT
Market By Demographics, Produc ..
VIEW REPORT
Market by Type, Sales Channel, ..
VIEW REPORT1. NORTH
AMERICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1.PARENT
MARKET ANALYSIS
2.2.IMPACT
ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19
IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA
WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S
FIVE FORCES ANALYSIS
2.3.1.THREAT
OF NEW ENTRANTS
2.3.2.THREAT
OF SUBSTITUTES
2.3.3.BARGAINING
POWER OF BUYERS
2.3.4.BARGAINING
POWER OF SUPPLIERS
2.3.5.THREAT
OF COMPETITIVE RIVALRY
2.4.MARKET
MATURITY ANALYSIS
2.5.INDUSTRY
COMPONENTS
2.5.1.RESEARCH
AND DEVELOPMENT
2.5.2.MANUFACTURING
OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES
MONITORING
2.6.REGULATORY
FRAMEWORK
2.7.KEY
BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND
NAME
2.7.3.USABILITY
2.8.KEY
MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT
LAUNCHES
2.8.3.MERGERS
& ACQUISITIONS
2.8.4.BUSINESS
DIVESTITURES & EXPANSIONS
2.9.MARKET
DRIVERS
2.9.1.GROWING
PREVALENCE OF OBESITY
2.9.2.RAPIDLY
GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING
DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET
CHALLENGES
2.10.1.LACK
OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH
PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS
ASSOCIATED POST-TREATMENT
2.11.MARKET
OPPORTUNITIES
2.11.1.RISING
BEAUTY CONSCIOUSNESS
2.11.2.INCREASING
TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING
DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING
POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS
IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST
PERSPECTIVE
3. NORTH
AMERICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT
CELLULITE
3.2.HARD
CELLULITE
3.3.EDEMATOUS
CELLULITE
4. NORTH
AMERICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY
INVASIVE
4.3.TOPICAL
5. NORTH
AMERICA CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS
AND BEAUTY CENTERS
5.3.OTHER
END-USERS
6. NORTH
AMERICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY
ANALYSIS
6.1.1.UNITED
STATES
6.1.1.1.UNITED
STATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.CANADA
6.1.2.1.CANADA
CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1.JOHNSON
& JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT
PORTFOLIO
7.1.3.KEY
STRENGTHS
7.1.4.KEY
CHALLENGES
7.2.ABBVIE
INC
7.2.1.OVERVIEW
7.2.2.PRODUCT
PORTFOLIO
7.2.3.KEY
STRENGTHS
7.2.4.KEY
CHALLENGES
7.3.BAUSCH
HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT
PORTFOLIO
7.3.3.KEY
STRENGTHS
7.3.4.KEY
CHALLENGES
7.4.CUTERA
INC
7.4.1.OVERVIEW
7.4.2.PRODUCT
PORTFOLIO
7.4.3.KEY
STRENGTHS
7.4.4.KEY
CHALLENGES
7.5.INCELER
MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT
PORTFOLIO
7.5.3.KEY
STRENGTHS
7.5.4.KEY
CHALLENGES
7.6.ZIMMER
MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT
PORTFOLIO
7.6.3.KEY
STRENGTHS
7.6.4.KEY
CHALLENGES
7.7.GALDERMA
SA
7.7.1.OVERVIEW
7.7.2.PRODUCT
PORTFOLIO
7.7.3.KEY
STRENGTHS
7.7.4.KEY
CHALLENGES
7.8.SIENTRA
INC
7.8.1.OVERVIEW
7.8.2.PRODUCT
PORTFOLIO
7.8.3.KEY
STRENGTHS
7.8.4.KEY
CHALLENGES
7.9.ENDO
INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT
PORTFOLIO
7.9.3.KEY
STRENGTHS
7.9.4.KEY
CHALLENGES
7.10.CANDELA
MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT
PORTFOLIO
7.10.3.KEY
STRENGTHS
7.10.4.KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1.RESEARCH
SCOPE & DELIVERABLES
8.1.1.OBJECTIVES
OF STUDY
8.1.2.SCOPE
OF STUDY
8.2.SOURCES
OF DATA
8.2.1.PRIMARY
DATA SOURCES
8.2.2.SECONDARY
DATA SOURCES
8.3.RESEARCH
METHODOLOGY
8.3.1.EVALUATION
OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION
OF DATA SOURCES
8.3.3.ASSESSMENT
OF MARKET DETERMINANTS
8.3.4.DATA
COLLECTION
8.3.5.DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF
PRODUCT LAUNCHES
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH
AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $
MILLION)
FIGURE 1: MARKET
MATURITY ANALYSIS
FIGURE 2: INDUSTRY
COMPONENTS
FIGURE 3: KEY BUYING
IMPACT ANALYSIS
FIGURE 4: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: NORTH
AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: NORTH
AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030
(IN $ MILLION)
FIGURE 14: NORTH
AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $
MILLION)
FIGURE 15: NORTH AMERICA
CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED
STATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: CANADA
CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)